Cargando…
PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE.
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429502/ http://dx.doi.org/10.1097/01.HS9.0000976080.53739.d2 |
| _version_ | 1785090730985783296 |
|---|---|
| author | Zahra, Kmira Belaid, Imtinène Kacem, Karima Elloumi, Moez Mezlini, Amel Msaddek, Fehmi Tarek, Ben Othman Nabil, Toumi Lakhal, Raihane Ben Khelif, Abderrahim Slim, Ben Ahmed Afef, Khanfir Laatiri, Adnene |
| author_facet | Zahra, Kmira Belaid, Imtinène Kacem, Karima Elloumi, Moez Mezlini, Amel Msaddek, Fehmi Tarek, Ben Othman Nabil, Toumi Lakhal, Raihane Ben Khelif, Abderrahim Slim, Ben Ahmed Afef, Khanfir Laatiri, Adnene |
| author_sort | Zahra, Kmira |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429502 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104295022023-08-17 PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE. Zahra, Kmira Belaid, Imtinène Kacem, Karima Elloumi, Moez Mezlini, Amel Msaddek, Fehmi Tarek, Ben Othman Nabil, Toumi Lakhal, Raihane Ben Khelif, Abderrahim Slim, Ben Ahmed Afef, Khanfir Laatiri, Adnene Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429502/ http://dx.doi.org/10.1097/01.HS9.0000976080.53739.d2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Zahra, Kmira Belaid, Imtinène Kacem, Karima Elloumi, Moez Mezlini, Amel Msaddek, Fehmi Tarek, Ben Othman Nabil, Toumi Lakhal, Raihane Ben Khelif, Abderrahim Slim, Ben Ahmed Afef, Khanfir Laatiri, Adnene PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE. |
| title | PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE. |
| title_full | PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE. |
| title_fullStr | PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE. |
| title_full_unstemmed | PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE. |
| title_short | PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE. |
| title_sort | pb2340: first line therapy for diffuse large b cell lymphoma amongpatients aged less than 60 years: a tunisian multicenter experience. |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429502/ http://dx.doi.org/10.1097/01.HS9.0000976080.53739.d2 |
| work_keys_str_mv | AT zahrakmira pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT belaidimtinene pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT kacemkarima pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT elloumimoez pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT mezliniamel pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT msaddekfehmi pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT tarekbenothman pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT nabiltoumi pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT lakhalraihaneben pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT khelifabderrahim pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT slimbenahmed pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT afefkhanfir pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience AT laatiriadnene pb2340firstlinetherapyfordiffuselargebcelllymphomaamongpatientsagedlessthan60yearsatunisianmulticenterexperience |